e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Treatment of tuberculosis at times of emerging drug resistance
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The experience of complex treatment of XDR-TB patients
I. A. Vasilyeva, V. I. Chukanov, T. R. Bagdasaryan (Moscow, Russian Federation)
Source:
Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Session:
Treatment of tuberculosis at times of emerging drug resistance
Session type:
E-Communication Session
Number:
213
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. A. Vasilyeva, V. I. Chukanov, T. R. Bagdasaryan (Moscow, Russian Federation). The experience of complex treatment of XDR-TB patients. Eur Respir J 2009; 34: Suppl. 53, 213
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Linezolide in complex treatment of XDR-TB patients
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Experience of Bedaquiline use in treatment of XDR-TB patients
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
Source: Eur Respir J, 50 (1) 1700311; 10.1183/13993003.00311-2017
Year: 2017
Impact of XDR-TB on treatment outcome of MDR-TB patients with standardized regimens
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
DOTS-Plus treatment of MDR-TB patients with psychiatric disorders
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Treatment outcomes for XDR TB patients with surgery
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
The relapses of tuberculosis with multiple drug resistance among patients treated under DOTS-Plus regimen
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Treatment results for MDR TB patients after surgery
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005
Treatment outcomes of extensively-drug resistant tuberculosis (XDR-TB) patients in 20 countries
Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment
Year: 2012
The depressive syndrome as a response to the TB treatment in MDR TB patients
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
The clinical features and treatment of cases with MDR TB of adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
MDR-TB treatment in prison setting
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007
Managing adult and children XDR-TB cases with limited clinical options
Source: International Congress 2018 – CC4 Tuberculosis
Year: 2018
Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens
Source: Eur Respir J, 50 (5) 1701105; 10.1183/13993003.01105-2017
Year: 2017
Psychiatric issues during the treatment of the patients with multidrug-resistant tuberculosis
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
The assessment of the efficacy of a standard chemotherapy regimen in the treatment of new sputum-positive tuberculosis (TB) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 340s
Year: 2001
MDR-TB and XDR-TB: drug resistance and treatment outcomes
Source: Eur Respir J 2009; 34: 778
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept